Diana Giannarelli

Research interests

Publications

• Sequencing of Ipilimumab Plus Nivolumab and Encorafenib Plus Binimetinib for Untreated BRAF-Mutated Metastatic Melanoma (SECOMBIT): A Randomized, Three-Arm, Open-Label Phase II Trial

  Journal of Clinical Oncology · 2022 · https://doi.org/10.1200/jco.21.02961

• Initial observations on age, gender, BMI and hypertension in antibody responses to SARS-CoV-2 BNT162b2 vaccine

  EClinicalMedicine · 2021 · https://doi.org/10.1016/j.eclinm.2021.100928

• Fifth-week immunogenicity and safety of anti-SARS-CoV-2 BNT162b2 vaccine in patients with multiple myeloma and myeloproliferative malignancies on active treatment: preliminary data from a single institution

  Journal of Hematology & Oncology · 2021 · https://doi.org/10.1186/s13045-021-01090-6

• Association of Systemic Inflammation Index and Body Mass Index with Survival in Patients with Renal Cell Cancer Treated with Nivolumab

  Clinical Cancer Research · 2019 · https://doi.org/10.1158/1078-0432.ccr-18-3661

• Crizotinib in MET -Deregulated or ROS1 -Rearranged Pretreated Non–Small Cell Lung Cancer (METROS): A Phase II, Prospective, Multicenter, Two-Arms Trial

  Clinical Cancer Research · 2019 · https://doi.org/10.1158/1078-0432.ccr-19-0994

• Bone metastases and immunotherapy in patients with advanced non-small-cell lung cancer

  Journal for ImmunoTherapy of Cancer · 2019 · https://doi.org/10.1186/s40425-019-0793-8

• Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab

  Journal for ImmunoTherapy of Cancer · 2018 · https://doi.org/10.1186/s40425-018-0383-1

• Use of nivolumab in elderly patients with advanced squamous non–small-cell lung cancer: results from the Italian cohort of an expanded access programme

  European Journal of Cancer · 2018 · https://doi.org/10.1016/j.ejca.2018.05.015

• Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumab

  Annals of Oncology · 2016 · https://doi.org/10.1093/annonc/mdw016

• Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers

  PLoS ONE · 2015 · https://doi.org/10.1371/journal.pone.0130142

• Baseline neutrophil-to-lymphocyte ratio is associated with outcome of ipilimumab-treated metastatic melanoma patients

  British Journal of Cancer · 2015 · https://doi.org/10.1038/bjc.2015.180

• Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanoma

  Cancer Immunology Immunotherapy · 2014 · https://doi.org/10.1007/s00262-014-1545-8

• Abscopal effects of radiotherapy on advanced melanoma patients who progressed after ipilimumab immunotherapy

  OncoImmunology · 2014 · https://doi.org/10.4161/onci.28780

• Tremelimumab for patients with chemotherapy-resistant advanced malignant mesothelioma: an open-label, single-arm, phase 2 trial

  The Lancet Oncology · 2013 · https://doi.org/10.1016/s1470-2045(13)70381-4

• Ipilimumab and fotemustine in patients with advanced melanoma (NIBIT-M1): an open-label, single-arm phase 2 trial

  The Lancet Oncology · 2012 · https://doi.org/10.1016/s1470-2045(12)70324-8

• Systematic Pelvic Lymphadenectomy vs No Lymphadenectomy in Early-Stage Endometrial Carcinoma: Randomized Clinical Trial

  JNCI Journal of the National Cancer Institute · 2008 · https://doi.org/10.1093/jnci/djn397

• Systematic Aortic and Pelvic Lymphadenectomy Versus Resection of Bulky Nodes Only in Optimally Debulked Advanced Ovarian Cancer: A Randomized Clinical Trial

  JNCI Journal of the National Cancer Institute · 2005 · https://doi.org/10.1093/jnci/dji102

• Temozolomide chemotherapy for progressive low-grade glioma: clinical benefits and radiological response

  Annals of Oncology · 2003 · https://doi.org/10.1093/annonc/mdg502

• Autoimmune hemolytic anemia in chronic lymphocytic leukemia: clinical, therapeutic, and prognostic features

  Blood · 2000 · https://doi.org/10.1182/blood.v95.9.2786.009k30_2786_2792

Current projects

No projects listed.